| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $116.4M | -17.9% |
| SG&A Expense | $26.1M | -8.4% |
| Operating Income | -$142.5M | +16.3% |
| Interest Expense | $1.7M | +10.5% |
| Pre-tax Income | -$134.8M | +16.1% |
| Income Tax | $64K | — |
| Net Income | -$134.8M | +16.1% |
| EPS (Basic) | -$2.58 | +31.0% |
| EPS (Diluted) | -$2.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.6M | -21.6% |
| Short-term Investments | $110.2M | -31.3% |
| Current Assets | $134.4M | -28.8% |
| Total Assets | $147.8M | -39.1% |
| Current Liabilities | $18.5M | -48.6% |
| Long-term Debt | $10.6M | +0.0% |
| Total Liabilities | $34.2M | -35.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$121.9M | +6.5% |
| Capital Expenditures | $447K | -64.9% |
| Investing Cash Flow | $86.3M | +93.2% |
| Financing Cash Flow | $30.8M | -48.0% |
| Free Cash Flow | -$122.4M | +7.0% |
| +31.0% |
| Stockholders' Equity |
| $113.6M |
| -40.1% |